CCL17 and esophageal squamous cell carcinoma: Besides, reduced expressions of metastasis-associated proteins MMP2 and MMP9 upon anti-CCL17 treatment also indicated that the promoting effects of M2-like macrophages-derived CCL17 on ESCC cell migration and invasion were partially abolished by anti-CCL17 treatment (Fig. 2C).